Search for Clinical Trial Results
Meningeal Neoplasms - 25 Studies Found
Status | Study |
Terminated |
Study Name: Depocyt® With Sorafenib in Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-08-24 Interventions:
|
Completed |
Study Name: A Pilot Study of Bevacizumab for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-06-18 Interventions: Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks. |
Completed |
Study Name: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-12-21 Interventions:
|
Terminated |
Study Name: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-08-13 Interventions:
|
Terminated |
Study Name: Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine Condition:
Date: 2003-12-16 Interventions: Drug: Gemcitabine Schedule |
Recruiting |
Study Name: Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors Condition: Leptomeningeal Metastasis Date: 2017-03-05 Interventions:
|
Not yet recruiting |
Study Name: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis Condition: Meningeal Carcinomatosis Date: 2015-10-26 Interventions: Drug: methotrexate The quantity of methotrexate is different in the two groups. |
Recruiting |
Study Name: Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) Condition: Leptomeningeal Metastasis Date: 2014-02-21 |
Recruiting |
Study Name: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Condition:
Date: 2017-03-08 Interventions: Drug: Selumetinib Continuous twice daily dosing; oral agent |
Not yet recruiting |
Study Name: Phase II Study Of Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas Condition: Meningioma Date: 2017-02-22 Interventions: Drug: AZD2014 AZD2014 is a dual mTORC1/mTORC2 inhibitor |